Understanding Post-translational Modifications to Circulating Histones Via Mass Spectrometry in Pregnant Women Developing Pre-eclampsia: A Retrospective Study

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

December 1, 2023

Conditions
Pregnancy RelatedPre-Eclampsia
Interventions
DIAGNOSTIC_TEST

Analysis of post-translational histone modifications via mass spectrometry

"During the GrossHist study (NCT04205383), only 3 post-translational histone modifications available in ELISA at the time were quantified thanks to a collaboration with the VOLITION™ company \[Bouvier and Fortier et al. 2021\]. The development of a new mass spectrometry approach based on nucleosome enrichment of plasma, developed by collaborators at VOLITION™, has made it possible to consider the description of all post-translational histone modifications (about 40 post-translational modifications involving histones H2A, H2B, H3 and H4)."

Trial Locations (1)

30900

Nîmes University Hospital, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT05142410 - Understanding Post-translational Modifications to Circulating Histones Via Mass Spectrometry in Pregnant Women Developing Pre-eclampsia: A Retrospective Study | Biotech Hunter | Biotech Hunter